Comparative study of modified HeRO grafts using bovine carotid artery as conduits versus polytetrafluoreythylene

Abstract

Objectives:

Hemodialysis reliable outflow (HeRO) device is currently the only option for hemodialysis for catheter-dependent dialysis patients with central venous stenosis who are poor candidates of fistulas and grafts. The proprietary HeRO device is connected to a standard polytetrafluorethylene (PTFE) conduit. Previous studies have showed decreased rates of infection using bovine carotid artery graft (BCAG) compared to the PTFE graft for arteriovenous grafts (AVG). This is the first study to compare the use of BCAG to PTFE for HeRO grafts.

Methods:

From Jan 2015 to Dec 2022 we inserted 83 HeRO grafts on ESRD patients, 40 cases used the standard PTFE graft as the conduit connected to the HeRO component and 43 cases used the BCAG grafts. We did a 2 year follow up review on all the patients using the Kaplan Meier’s survival analysis to compare the primary, primary-assisted patency and secondary patency, graft lifespan comparison, infection and complications.

Results:

PTFE was associated with significantly increased rates of infection compared to BCAG (40% vs 16.3%, p = 0.026). Comparing BCAG versus PTFE, primary patency was 58.4% versus 59% at 6 months (p = 0.82) and 34.9% versus 34.1% at 1 year (p = 0.88). Primary-assisted patency was 88.6% versus 80.6% at 6 months (p = 0.35) and 69.7% versus 54.6% at 1 year (p = 0.21). Secondary patency was 94.3% versus 85.7% (p = 0.23) at 6 months and 82.4% versus 59.1% at 1 year (p = 0.12).

Conclusions:

Bovine carotid artery grafts are comparable in primary patency, primary-assisted patency, and secondary patency versus PTFE. Number of interventions required and done were similar in both groups. BCAG was associated with lower rates of infection compared to PTFE. BCAG is an acceptable conduit for HeRO graft and may be a better option compared to PTFE.

Keywords

Dialysis access prosthetic grafts techniques and procedures biomaterials new devices

Get full access to this article

View all access options for this article.

References

United States Renal Data System. 2023 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2023.

Katzman

McLafferty

Ross

, et al. Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. J Vasc Surg 2009; 50: 600–607.e1.

Gage

Katzman

Ross

, et al. Multi-center experience of 164 consecutive hemodialysis reliable outflow [HeRO] graft implants for hemodialysis treatment. Eur J Vasc Endovasc Surg 2012; 44: 93–99.

Al Shakarchi

Houston

Jones

, et al. A review on the hemodialysis reliable outflow (HeRO) graft for haemodialysis vascular access. Eur J Vasc Endovasc Surg 2015; 50: 108–113.

Harlander-Locke

Jimenez

Lawrence

, et al. Bovine carotid artery (Artegraft) as a hemodialysis access conduit in patients who are poor candidates for native arteriovenous fistulae. Vasc Endovascular Surg 2014; 48: 497–502.

Pineda

Dougherty

Wismer

, et al. Bovine carotid artery xenografts for hemodialysis access. J Vasc Surg 2017; 65: 1729–1734.

Kostakis

Loukopoulos

Comparison between bovine carotid artery graft and polytetrafluoroethylene graft for haemodialysis vascular access: a systematic review and meta-analysis. J Vasc Access 2021; 22: 26–33.

Kennealey

Elias

Hertl

, et al. A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access. J Vasc Surg 2011; 53: 1640–1648.

Reilly

Khan

Dosluoglu

, et al. Comparison of autologous vein and bovine carotid artery graft as a bypass conduit in arterial trauma. Ann Vasc Surg 2019; 61: 246–253.

10.

Sidawy

Gray

Besarab

, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35: 603–610.

11.

Arhuidese

Reifsnyder

Islam

, et al. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access. J Vasc Surg 2017; 65: 775–782.

12.

Anderson

Sicard

Etheredge

, et al. Bovine carotid artery and expanded polytetrafluroethylene grafts for hemodialysis vascular access. J Surg Res 1980; 29: 184–188.

13.

Tellis

Kohlberg

Bhat

, et al. Expanded polytetrafluoroethylene graft fistula for chronic hemodialysis. Ann Surg 1979; 189: 101–105.

14.

Hertzer

Beven

EG.

Venous access using the bovine carotid heterograft: techniques, results, and complications in 75 patients. Arch Surg 1978; 113: 696–700.

15.

Lin

C-H

Hsia

, et al. In vivo performance of decellularized vascular grafts: a review article. Int J Mol Sci 2018; 19: 2101.

16.

Huynh

Abraham

Murray

, et al. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999; 17: 1083–1086.

17.

Sawyer

Fitzgerald

Kaplitt

, et al. Ten year experience with the negatively charged glutaraldehyde-tanned vascular graft in peripheral vascular surgery. Initial multicenter trial. Am J Surg 1987; 154: 533–537.